Evidence map›Paper›PMID 42165882›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026

Predictors of multidisciplinary tumor board implementation in head and neck cancer: Global insights.

Antonino Maniaci, Jerome R Lechien, Carlos Chiesa-Estomba, Victorine Maso, Fiona Kabagenyi, Isabelle Gengler, Johannes J Fagan, Sheng Po Hao, Luiz P Kowalski, Bernard Lyons and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Antonino ManiaciDepartment of Medicine and Surgery, University of Enna ″Kore″, Enna, 94100, Italy. antonino.maniaci@unikore.it.ORCID http://orcid.org/0000-0002-1251-0185
Jerome R LechienDivision of Laryngology and Bronchoesophagology, EpiCURA Hospital, University of Mons, Mons, Belgium.
Carlos Chiesa-EstombaHead and Neck Study Group of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
Victorine MasoDepartment of Oto-Rhino-Laryngology Head and Neck Surgery, AP-HM, La Conception University Hospital, Aix Marseille Université, Marseille, 13006, France.
Fiona KabagenyiHead and Neck Study Group of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
Isabelle GenglerFacial Plastic and Reconstructive Surgery, Department of Otolaryngology - Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Johannes J FaganDivision of Otolaryngology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Sheng Po HaoDepartment of Otolaryngology, Head and Neck Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Luiz P KowalskiHead and Neck Surgery and Otorhinolaryngology Department, A C Camargo Cancer Center, Sao Paulo, Brazil.
Bernard LyonsSt. Vincent's Health Melbourne, Melbourne, Australia.
Mohamad Yunus Mohd RazifDepartment of Otorhinolaryngology, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
Hani Z MarzoukiDepartment of Otolaryngology- Head & Neck Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Federica Maria ParisiDepartment of Medicine and Surgery, University of Enna ″Kore″, Enna, 94100, Italy.
Matthew WhiteDivision of Otolaryngology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Justin MichelDepartment of Oto-Rhino-Laryngology Head and Neck Surgery, AP-HM, La Conception University Hospital, Aix Marseille Université, Marseille, 13006, France.
Nicolas FakhryHead and Neck Study Group of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify institutional and organizational determinants associated with the adoption of multidisciplinary tumor boards (MDTBs) in head and neck cancer management across diverse healthcare settings.

methodsThis cross-sectional analysis used data from 566 responses, corresponding to 457 unique centers across 101 countries participating in the IFOS-YO-IFOS global survey. Centers were categorized by income level, region, and case volume. Logistic regression identified predictors of systematic MDTB use.

resultsAmong responding centers, MDTBs were systematic in 89.1% of North America, 88.9% of European and 87.5% of Oceanian centers, compared with 37.5% in Africa and 32.6% in MENA. High annual case volume (> 200 cases/year) (OR = 3.4, p < 0.001), university affiliation (OR = 2.7, p = 0.002), and access to intensity-modulated radiotherapy (OR = 2.1, p = 0.01) independently predicted full MDTB integration. Centers citing economic barriers showed a 65% reduction in odds of MDTB implementation.

conclusionsOur findings suggest that multidisciplinary management in head and neck oncology is strongly influenced by institutional resources and organizational models rather than geography alone. Strengthening MDTB frameworks in low- and middle-income regions could substantially narrow global care inequities.

Indexed as

Head and Neck NeoplasmsPatient Care TeamCross-Sectional StudiesGlobal HealthHumansGlobal oncologyHead and neck cancerImplementation scienceMultidisciplinary tumor boardResource-limited settings

Identifiers

PMID42165882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.